Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25


Correction for Fletcher et al., "Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein".

Fletcher LD, Bernfield L, Barniak V, Farley JE, Howell A, Knauf M, Ooi P, Smith RP, Weise P, Wetherell M, Xie X, Zagursky R, Zhang Y, Zlotnick GW.

Infect Immun. 2017 May 23;85(6). pii: e00212-17. doi: 10.1128/IAI.00212-17. eCollection 2017 Jun.


The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease.

Zlotnick GW, Jones TR, Liberator P, Hao L, Harris S, McNeil LK, Zhu D, Perez J, Eiden J, Jansen KU, Anderson AS.

Hum Vaccin Immunother. 2015;11(1):5-13. doi: 10.4161/hv.34293. Epub 2014 Nov 1. Review.


Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease.

McNeil LK, Zagursky RJ, Lin SL, Murphy E, Zlotnick GW, Hoiseth SK, Jansen KU, Anderson AS.

Microbiol Mol Biol Rev. 2013 Jun;77(2):234-52. doi: 10.1128/MMBR.00056-12. Review.


Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease.

Jiang HQ, Hoiseth SK, Harris SL, McNeil LK, Zhu D, Tan C, Scott AA, Alexander K, Mason K, Miller L, DaSilva I, Mack M, Zhao XJ, Pride MW, Andrew L, Murphy E, Hagen M, French R, Arora A, Jones TR, Jansen KU, Zlotnick GW, Anderson AS.

Vaccine. 2010 Aug 23;28(37):6086-93. doi: 10.1016/j.vaccine.2010.06.083. Epub 2010 Jul 7.


NMR dynamics and antibody recognition of the meningococcal lipidated outer membrane protein LP2086 in micellar solution.

Mascioni A, Moy FJ, McNeil LK, Murphy E, Bentley BE, Camarda R, Dilts DA, Fink PS, Gusarova V, Hoiseth SK, Malakian K, Mininni T, Novikova E, Lin S, Sigethy S, Zlotnick GW, Tsao DH.

Biochim Biophys Acta. 2010 Feb;1798(2):87-93. doi: 10.1016/j.bbamem.2009.09.021. Epub 2009 Oct 14.


Backbone and side-chain assignment of the lipidated and non-lipidated forms of the meningococcal outer membrane protein LP2086.

Mascioni A, Jacob J, Moy F, Dilts D, Fink P, Malakian K, Sigethy S, Wen Y, Novikova E, Zlotnick GW, Tsao DH.

Biomol NMR Assign. 2009 Jun;3(1):111-3. doi: 10.1007/s12104-009-9153-9. Epub 2009 Mar 5.


Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis.

Murphy E, Andrew L, Lee KL, Dilts DA, Nunez L, Fink PS, Ambrose K, Borrow R, Findlow J, Taha MK, Deghmane AE, Kriz P, Musilek M, Kalmusova J, Caugant DA, Alvestad T, Mayer LW, Sacchi CT, Wang X, Martin D, von Gottberg A, du Plessis M, Klugman KP, Anderson AS, Jansen KU, Zlotnick GW, Hoiseth SK.

J Infect Dis. 2009 Aug 1;200(3):379-89. doi: 10.1086/600141.


Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide.

McNeil LK, Murphy E, Zhao XJ, Guttmann S, Harris SL, Scott AA, Tan C, Mack M, DaSilva I, Alexander K, Mason K, Jiang HQ, Zhu D, Mininni TL, Zlotnick GW, Hoiseth SK, Jones TR, Pride MW, Jansen KU, Anderson AS.

Vaccine. 2009 May 26;27(25-26):3417-21. doi: 10.1016/j.vaccine.2009.01.075. Epub 2009 Feb 5.


Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086.

Mascioni A, Bentley BE, Camarda R, Dilts DA, Fink P, Gusarova V, Hoiseth SK, Jacob J, Lin SL, Malakian K, McNeil LK, Mininni T, Moy F, Murphy E, Novikova E, Sigethy S, Wen Y, Zlotnick GW, Tsao DH.

J Biol Chem. 2009 Mar 27;284(13):8738-46. doi: 10.1074/jbc.M808831200. Epub 2008 Dec 22.


Vaccine potential of the Neisseria meningitidis 2086 lipoprotein.

Fletcher LD, Bernfield L, Barniak V, Farley JE, Howell A, Knauf M, Ooi P, Smith RP, Weise P, Wetherell M, Xie X, Zagursky R, Zhang Y, Zlotnick GW.

Infect Immun. 2004 Apr;72(4):2088-100. Erratum in: Infect Immun. 2017 May 23;85(6):.


Contribution of the DDDD motif of H. influenzae e (P4) to phosphomonoesterase activity and heme transport.

Reilly TJ, Green BA, Zlotnick GW, Smith AL.

FEBS Lett. 2001 Apr 6;494(1-2):19-23.


Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model.

Green BA, Vazquez ME, Zlotnick GW, Quigley-Reape G, Swarts JD, Green I, Cowell JL, Bluestone CD, Doyle WJ.

Infect Immun. 1993 May;61(5):1950-7.


Purification and characterization of the 3'-nucleotidase/nuclease from promastigotes of Leishmania donovani.

Campbell TA, Zlotnick GW, Neubert TA, Sacci JB Jr, Gottlieb M.

Mol Biochem Parasitol. 1991 Jul;47(1):109-17.


Antigenic conservation of the 15,000-dalton outer membrane lipoprotein PCP of Haemophilus influenzae and biologic activity of anti-PCP antisera.

Deich RA, Anilionis A, Fulginiti J, Metcalf BJ, Quataert S, Quinn-Dey T, Zlotnick GW, Green BA.

Infect Immun. 1990 Oct;58(10):3388-93.


Purification and characterization of a peptidoglycan-associated lipoprotein from Haemophilus influenzae.

Zlotnick GW, Sanfilippo VT, Mattler JA, Kirkley DH, Boykins RA, Seid RC Jr.

J Biol Chem. 1988 Jul 15;263(20):9790-4.


Renaturation of Leishmania donovani 3'-nucleotidase following sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Zlotnick GW, Mackow MC, Gottlieb M.

Comp Biochem Physiol B. 1987;87(3):629-35.


Ion extrusion systems in bacteria.

Rosen BP, Ambudkar SV, Borbolla MG, Chen CM, Houng HS, Mobley HL, Tsujibo H, Zlotnick GW.

Ann N Y Acad Sci. 1985;456:235-44. Review. No abstract available.


Calcium efflux from Escherichia coli. Evidence for two systems.

Ambudkar SV, Zlotnick GW, Rosen BP.

J Biol Chem. 1984 May 25;259(10):6142-6.


Calcium, sodium, phosphate and arsenate transport in cells and vesicles of Escherichia coli.

Rosen BP, Ambudkar SV, Borbolla MG, Chen CM, Mobley HL, Tsujibo H, Zlotnick GW.

Prog Clin Biol Res. 1984;168:219-26. No abstract available.


Supplemental Content

Loading ...
Support Center